Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention

Published on May 1, 2014in Current Cardiovascular Risk Reports
· DOI :10.1007/S12170-014-0390-9
Lan Shen1
Estimated H-index: 1
(Duke University),
Chiara Melloni27
Estimated H-index: 27
(Duke University)
Cardiovascular disease (CVD) is the leading cause of mortality in women. Differences in pathophysiology, diagnosis, and treatment of women with cardiovascular disease compared with men have become a major focus during the past decades. Guideline of CVD prevention in women drew heavily on the results of randomized clinical trials (RCT). However, data from RCT in women was limited, leading to concerns of women been underrepresented in clinical trials from which guidelines were generated. During the past several years, researchers, physicians, and regulators have made substantial efforts to improve understanding of the sex difference in CVD and to recognize the importance of heart disease in women. The purpose of this review is to evaluate contemporary sex differences in CVD disease management, current representation of women in RCT, and examine factors that may improve women’s representation and quality of care in CVD prevention in women.
📖 Papers frequently viewed together
2 Citations
5 Citations
#1Cheryl BushnellH-Index: 54
Last. Matthew WaltersH-Index: 48
view all 17 authors...
Purpose— The aim of this statement is to summarize data on stroke risk factors that are unique to and more common in women than men and to expand on the data provided in prior stroke guidelines and cardiovascular prevention guidelines for women. This guideline focuses on the risk factors unique to women, such as reproductive factors, and those that are more common in women, including migraine with aura, obesity, metabolic syndrome, and atrial fibrillation. Methods— Writing group members were nom...
522 CitationsSource
#1José Fernández-Sáez (University of Alicante)H-Index: 4
#2María Teresa Ruiz-Cantero (University of Alicante)H-Index: 13
Last. Carlos Álvarez-Dardet (University of Alicante)H-Index: 28
view all 7 authors...
Background It has been shown that gender equity has a positive impact on the everyday activities of people (decision making, income allocation, application and observance of norms/rules) which affect their health. Gender equity is also a crucial determinant of health inequalities at national level; thus, monitoring is important for surveillance of women’s and men’s health as well as for future health policy initiatives. The Gender Equity Index (GEI) was designed to show inequity solely towards w...
9 CitationsSource
#2Gender DifferencesH-Index: 4
Last. Mary-Lou PardueH-Index: 5
view all 3 authors...
1 Front Matter 2 Executive Summary 3 1 Introduction 4 2 Every Cell Has a Sex 5 3 Sex Begins in the Womb 6 4 Sex Affects Behavior and Perception 7 5 Sex Affects Health 8 6 The Future of Research on Biological Sex Differences: Challenges and Opportunities 9 References 10 Appendix A: Data Sources and Acknowledgments 11 Appendix B: Physiological and Pharmacological Differences Between the Sexes 12 Appendix C: Glossary 13 Appendix D: Committee and Staff Biographies 14 Index
593 Citations
#1Alan S. Go (CDC: Centers for Disease Control and Prevention)H-Index: 124
#2Dariush Mozaffarian (CDC: Centers for Disease Control and Prevention)H-Index: 152
Last. Melanie B. Turner (CDC: Centers for Disease Control and Prevention)H-Index: 16
view all 40 authors...
Author(s): Go, Alan S; Mozaffarian, Dariush; Roger, Veronique L; Benjamin, Emelia J; Berry, Jarett D; Borden, William B; Bravata, Dawn M; Dai, Shifan; Ford, Earl S; Fox, Caroline S; Franco, Sheila; Fullerton, Heather J; Gillespie, Cathleen; Hailpern, Susan M; Heit, John A; Howard, Virginia J; Huffman, Mark D; Kissela, Brett M; Kittner, Steven J; Lackland, Daniel T; Lichtman, Judith H; Lisabeth, Lynda D; Magid, David; Marcus, Gregory M; Marelli, Ariane; Matchar, David B; McGuire, Darren K; Mohler...
4,519 CitationsSource
#1Carolyn S.P. Lam (Wake Forest University)H-Index: 78
#2William C. Little (Wake Forest University)H-Index: 77
There are more women than men living with cardiovascular disease, and the absolute annual number of cardiovascular deaths among women exceeds that in men.1 Although sex differences in cardiovascular risk are recognized in the risk stratification tools (eg, Framingham Risk Score, CHA2DS2-VASc score) and sex-specific risk management guidelines developed for clinical practice, it has to be recognized that women remain underrepresented in clinical trials. Approximately half of the individuals with h...
11 CitationsSource
Abstract There is mounting scientific evidence pointing to genetic or physiologic distinctions between genders and among racial and ethnic groups that influence disease risk and severity and response to treatment. The diverse enrollment of subjects engaged in clinical trials research is, thus, critical to developing safer and more effective drugs and medical devices. However, in the United States, there are striking disparities in clinical trial participation. To address this problem, the Food a...
86 CitationsSource
#1Sanket S. Dhruva (UCSF: University of California, San Francisco)H-Index: 22
#2Rita F. RedbergH-Index: 69
THE SAFETY AND EFFECTIVENESS OF MEDICAL TREATments can differ in men and women for many reasons related to different epidemiologic characteristics, physiology, and body size. In general, women have higher bleeding rates and procedural morbidity and mortality than men, which means that their risk/benefit ratios for many implanted medical devices can differ from men. Therefore, sex-specific safety and effectiveness data are necessary for informed patient decision making. In 2008, the US Food and D...
23 CitationsSource
#1Lori Mosca (CUMC: Columbia University Medical Center)H-Index: 54
Last. Nanette K. WengerH-Index: 94
view all 3 authors...
Over the past decade, scientists, healthcare providers, the public, and policy makers have made substantial efforts to improve understanding of the sex/gender*differences in cardiovascular disease (CVD)†and to recognize the importance of heart disease in women. Federal and American Heart Association (AHA) initiatives to raise awareness and to reduce gender disparities in research and clinical care are listed in Table 1. There was a near doubling of the rate of awareness of heart disease as the l...
542 CitationsSource
Diversity in both biological attributes and the external, lived environment gives rise to different susceptibilities, exposures, health outcomes, and longevity. Public policy can modify the effects of external differences, if groups at greatest risk are identified and pathways to excess vulnerability are understood, by rebalancing and redistributing the inputs or social determinants that work their way under the skin to ultimately cause biological disadvantage. In the past three decades, a large...
30 CitationsSource
#1Judith Feinberg (UC: University of Cincinnati)H-Index: 54
#2Michael S. SaagH-Index: 122
Last. Joseph M. MrusH-Index: 23
view all 7 authors...
Background. We report health-related QoL (HRQoL) from GRACE (Gender, Race, And Clinical Experience) study by sex and race over 48 weeks. Methods. 429 treatment-experienced adults (HIV-1 RNA≥1000 copies/mL) received darunavir/ritonavir 600/100 mg twice daily plus an appropriate background regimen. QoL was measured by the Functional Assessment of HIV Infection (FAHI) questionnaire. Results. 67% women and 77% men, including 67.4% black, 76.0% Hispanic, and 73.8% white patients, completed the trial....
10 CitationsSource
Cited By7
Resumen Introduccion Varios estudios han identificado un peor control de los factores de riesgo cardiovascular en el sexo femenino en pacientes con diabetes tipo 2. Una de sus causas podria ser el desconocimiento sobre el perfil de riesgo cardiovascular de la mujer con diabetes tipo 2 por parte de los profesionales. Objetivo Conocer la percepcion y el conocimiento de los profesionales de la salud involucrados en el manejo de los pacientes con diabetes tipo 2, del impacto que las diferencias de g...
#1Annamaria De Bellis (UniTS: University of Trieste)H-Index: 1
#2Giulia De Angelis (UniTS: University of Trieste)H-Index: 5
Last. Gianfranco Sinagra (UniTS: University of Trieste)H-Index: 64
view all 6 authors...
Cardiovascular diseases show many sex-related differences in prevalence, etiology, phenotype expression, and outcomes. Complex molecular mechanisms underlie this diverse pathological manifestation, from sex-determined differential gene expression to sex hormones interaction with their specific receptors in different tissues. More recently, differential non-coding RNAs regulation also turned out to be an involved mechanism. This review focuses on sex impact on the various heart failure syndromes,...
18 CitationsSource
#1Aneela Rahman (Cornell University)H-Index: 9
#2Hande Jackson (Cornell University)H-Index: 2
Last. Lisa Mosconi (NYU: New York University)H-Index: 58
view all 10 authors...
Research indicates that after advanced age, the major risk factor for late-onset Alzheimer’s disease is female sex. Out of every three AD patients, two are females with postmenopausal women contributing to over 60% of all those affected. Sex and gender related differences in AD have been widely researched and several emerging lines of evidence point to different vulnerabilities that contribute to dementia risk. Among those being considered, it is becoming widely accepted that gonadal steroids co...
24 CitationsSource
#1Thomas S. Gruca (UI: University of Iowa)H-Index: 23
#2Wesley J. Hottel (UI: University of Iowa)H-Index: 1
Last. Gary E. Rosenthal (Wake Forest University)H-Index: 68
view all 5 authors...
While women are under-represented in research on cardiovascular disease (CVD), little is known about the attitudes of men and women with CVD regarding participation in clinical research studies/clinical trials. Patients with CVD (and/or risk factors) and patients with other chronic conditions from Iowa were recruited from a commercial panel. An on-line survey assessed willingness to participate (WTP) and other attitudes towards aspects of clinical research studies. Based on 504 respondents, ther...
3 CitationsSource
#1Mohamed B. Elshazly (University of Adelaide)H-Index: 14
#2Brian StegmanH-Index: 8
Last. Rishi PuriH-Index: 51
view all 3 authors...
This article reviews coronary atheroma regression with statin therapy.Unlocking the mechanisms of atherogenesis and plaque progression has been fundamental to understanding the means by which contemporary antiatherosclerotic therapies lower cardiovascular risk. The advent of intracoronary imaging has helped chart the natural course of coronary atherosclerosis and evaluate therapeutic strategies that modify its natural progression. From earlier intravascular ultrasonography studies using lower do...
9 CitationsSource
#1Joy L. Johnson (UBC: University of British Columbia)H-Index: 60